Patents In Pharmaceuticals: Balancing Innovation And Access

Introduction

The pharmaceutical industry sits at the intersection of two equally compelling public interests: the need to reward innovation and the need to ensure access to life-saving medications. Patents are designed to encourage investment in research and development (“R&D”) by granting innovators a period of exclusivity. Yet, when those patented medicines are priced beyond the reach of patients or governments, questions inevitably arise about whether the patent system is serving public health.

For developing economies such as Nigeria, the challenge is not simply whether patents should exist, but how to structure a patent ecosystem that encourages pharmaceutical innovation while ensuring access to medicines. This question has become increasingly important as countries seek to strengthen local manufacturing, attract investment, respond to public health emergencies, and build innovation driven economies.